Where does Armo Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Armo Biosciences, Inc. ranks #20,763 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Armo Biosciences, Inc. hold?

Armo Biosciences, Inc. holds 13 US utility patents granted between 2017 and 2022, spanning 7 technology areas.

What is Armo Biosciences, Inc.'s Innovation Score?

Armo Biosciences, Inc. has an Innovation Score of 30.7 out of 100 (35th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Armo Biosciences, Inc. focus on?

Armo Biosciences, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 11 patents, ranking #1,740 of 6,058 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Armo Biosciences, Inc.'s patent grant rate increasing or decreasing?

Armo Biosciences, Inc.'s recent grant velocity is -70% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Armo Biosciences, Inc.'s patents?

Armo Biosciences, Inc.'s patents average 18.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Armo Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Armo Biosciences, Inc.

USPTO PatentsView assignee record - 13 granted patents across 7 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Armo ranks #20,763 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 7 technology areas.

#20,763
of 49,997 US assignees by volume: 35th percentile
by Innovation Score (30.7/100): 18.9
avg claims per patent: -70%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20763 · US Corporation #20,763 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,763/49,997
PHOTO-FINISH Arinc Incorporated
CPC-NARROW A61P · 7 areas
INNOV-THIN 30.7/100
CLAIMS-RICH 18.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -70% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Arinc Incorporated (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Armo’s 30.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (30%) Velocity 0.8 pts (3%) Breadth 9.4 pts (31%) Claim depth 11.4 pts (37%)

Qualcomm Incorporated · highest

85
Armo Biosciences · this assignee

31
3D Lighting… · lowest

7

What this shows Armo's Innovation Score is 30.7/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Armo?

Each dot is one of Armo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Armo’s own 18.9 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Armo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Armo's grants concentrate

Armo Biosciences, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 84.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2017. By volume, Armo sits between Arinc Incorporated and Artery Technology Company.

Armo's three-year grant acceleration

Armo Biosciences, Inc. shows 1 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Arinc Incorporated

13
Arkamys

13
Arlanxeo Netherla…

13
Armacell Enterpri…

13
Arnold Umformtech…

13
Aroma System S R L

13
Arrien Pharmaceut…

13
Artery Technology

13
Armo Biosciences ◀

13

What this shows Armo holds 13 patents at rank #20,722, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Armo

By rank, the assignees closest to #20,722 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Armo's primary technology class.

Armo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 35th percentile higher than 35% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Armo Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	7.7%
2018	3	23.1%
2019	6	46.2%
2020	2	15.4%
2022	1	7.7%

Which technologies does Armo Biosciences, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 11

C07K - Peptides 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Armo Biosciences, Inc.'s patent record in context - here's where to go next.

Armo Biosciences, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 84.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #20,763 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Armo Biosciences, Inc. against Arinc Incorporated, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.